5,875 followers
New Research: Cost-effectiveness analysis of olaparib as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation in china https://t.co/SAv6ggE8Nt #pharmacology
New Research: Cost-effectiveness analysis of olaparib as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation in china https://t.co/SAv6ggE8Nt #pharmacology